Osteoporosis in beta-thalassemia: Clinical and genetic aspects

Ann N Y Acad Sci. 2005:1054:451-6. doi: 10.1196/annals.1345.051.

Abstract

Osteoporosis and osteopenia are frequent complications of thalassemia major (TM) and intermedia (TI). Osteoporosis was found in 23/25 patients with TI and in 115/239 patients with TM. In TM, no association was found with specific polymorphisms in candidate genes (vitamin D receptor, estrogen receptor, calcitonin receptor, and collagen type 1 alpha 1). Osteoporosis in female patients with TM was strongly associated with primary amenorrhea (P < .0001), while in male patients with TM, hypogonadism was not significantly related to bone mineral density (BMD) (P = .0001). Low BMD was also associated with cardiomiopathy (P = .01), diabetes mellitus (P = .0001), chronic hepatitis (P = .0029), and increased ALT (P = .01).

MeSH terms

  • Adult
  • Amenorrhea / etiology
  • Bone Density
  • Bone Diseases, Metabolic / etiology
  • Bone Diseases, Metabolic / genetics
  • Cardiomyopathies / etiology
  • Collagen Type I / genetics
  • DNA Mutational Analysis
  • Diabetes Mellitus / etiology
  • Estrogen Receptor alpha / genetics
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Hypogonadism / etiology
  • Hypothyroidism / etiology
  • Male
  • Osteoporosis / etiology*
  • Osteoporosis / genetics
  • Receptors, Calcitonin / genetics
  • Receptors, Calcitriol / genetics
  • beta-Thalassemia / complications*
  • beta-Thalassemia / genetics

Substances

  • Collagen Type I
  • Estrogen Receptor alpha
  • Receptors, Calcitonin
  • Receptors, Calcitriol